ArticleBMC microbiology2026
Functional characterization of the oligopeptide transporter operon oppABCDF-1 in Escherichia coli Nissle 1917.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThe ABC-type oligopeptide transporter (Opp system), composed of five subunits (OppA-F), plays an essential role in microbial fitness and survival by mediating the uptake of short peptides. Paradoxically, although the probiotic strain Escherichia coli Nissle 1917 (EcN) harbors multiple Opp systems, it exhibits a defect in the import of oligopeptides comprising three or more amino acids, a limitation that may compromise its ability to colonize the intestinal tract. This functional paradox underscores the need for further investigation into the substrate specificity and physiological roles of Opp systems in EcN.
resultsGenomic analysis identified four putative Opp systems in EcN, which exhibited low mutual homology (< 41% amino acid identity across all OppA-OppF components), indicating potential functional divergence. Deletion or overexpression of one of the operons, oppABCDF-1 (ECOLIN_07295-07315) did not alter EcN growth under standard or oligopeptide-supplemented conditions. Untargeted metabolomics further demonstrated that this operon was dispensable for oligopeptide uptake. Notably, metabolic profiling revealed significantly impaired uptake of three metabolites in the oppABCDF-1 deletion mutant, along with a modest reduction in the export of putrescine, austinoneol, and leucinic acid. These findings suggest that this Opp system may function as a bidirectional transporter with differential import and export activities.
conclusionThese findings indicate that the oppABCDF-1 operon encoded by ECOLIN_07295-07315 in EcN is dispensable for oligopeptide assimilation, but may contribute to the transport of specific metabolites, offering new insights into the functional diversification of bacterial Opp systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.